No items found.
BreezeMeds is a newer telehealth platform offering compounded GLP-1 injections starting at $199/month with no subscription required. They also offer NAD+ injections starting at $169/month. The platform partners with multiple licensed compounding pharmacies including Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx. BreezeMeds was not included in the FDA's September 2025 warning letter wave, but has no Trustpilot presence and very limited independent reviews, making real patient experiences difficult to verify.
Competitive pricing at $199/month for semaglutide injections with no subscription or membership fees. The platform partners with established compounding pharmacies and lists named physicians with verifiable NPI numbers (Dr. Ana Lisa Carr MD and Dr. Kelly Tenbrink MD through Lion MD). FSA/HSA payments are accepted, and shipping is free. The no-subscription model means patients aren't locked into recurring billing.
The biggest concern with BreezeMeds is their lack of established track record. Independent reviews on platforms like Trustpilot are virtually nonexistent, making it difficult to assess real patient experiences. The 2-3 week timeline from consultation to medication delivery is slower than some competitors who ship within days. Additionally, much of the positive content about BreezeMeds online appears to be promotional rather than from verified patients.
BreezeMeds offers an appealing combination of competitive pricing and medication variety, particularly for patients interested in oral GLP-1 options. However, the platform's limited track record means prospective patients should proceed with appropriate caution. Request detailed information about pharmacy sourcing and provider credentials before committing. For patients comfortable with newer platforms and attracted to the oral medication options, BreezeMeds could be worth exploring.
BreezeMeds offers three medication tiers: compounded semaglutide injections starting at $199/month, oral semaglutide at $299/month, and oral tirzepatide at $399/month. Pricing includes consultation, prescription, and expedited delivery with no hidden fees. Multi-month plans (3, 6, or 12 months) offer additional discounts.
BreezeMeds prescribes three GLP-1 medication options: weekly semaglutide injections (the most popular choice), daily oral semaglutide tablets for needle-free treatment, and daily oral tirzepatide tablets which offer dual GLP-1/GIP receptor activity for enhanced weight loss results. All medications are compounded formulations.
The process is fully online: complete a brief health questionnaire from home, then a licensed board-certified provider reviews your information, confirms safe use, and develops a personalized treatment plan. Once approved, medication ships discreetly to your door. The entire process from consultation to receiving medication typically takes 2-3 weeks.
BreezeMeds operates on a cash-pay model and does not directly bill insurance companies. However, the platform is FSA and HSA eligible, so patients with flexible spending or health savings accounts can use pre-tax dollars to pay for treatment. This can effectively reduce out-of-pocket costs by 20-40% depending on your tax bracket.
BreezeMeds operates with licensed, board-certified healthcare providers who review each patient's medical history before prescribing. Medications are sourced from licensed pharmacies. However, as a newer platform, BreezeMeds has limited independent reviews on third-party sites. Patients should verify provider credentials and understand that compounded medications are not FDA-approved.
